Research Article
The Roles of EXO1 and RPA1 Polymorphisms in Prognosis of Lung Cancer Patients Treated with Platinum-Based Chemotherapy
Table 1
The 19 single nucleotide polymorphisms examined in this study.
| Gene | SNPs | Alleles | MAF | Call rates (%) |
| EXO1 | rs1047840 | G/AC | 0.35 | 97.03 | EXO1 | rs1776148 | A/GT | 0.32 | 97.78 | EXO1 | rs735943 | A/G | 0.36 | 97.78 | PMS1 | rs5742933 | G/AC | 0.22 | 96.30 | PMS2 | rs1062372 | C/AGT | 0.23 | 95.56 | PMS2 | rs2228006 | T/ACG | 0.12 | 99.01 | RPA1 | rs17292622 | G/AT | 0.22 | 98.84 | RPA1 | rs17339382 | G/A | 0.09 | 92.28 | RPA1 | rs3744768 | G/A | 0.20 | 98.55 | RPA1 | rs12727 | G/C | 0.24 | 98.26 | RPA1 | rs17339395 | G/ACT | 0.22 | 98.55 | RPA1 | rs9914073 | A/CG | 0.23 | 98.26 | RPA1 | rs9082 | T/C | 0.23 | 98.84 | RPA1 | rs3744766 | C/G | 0.22 | 98.84 | RPA1 | rs1131636 | C/AGT | 0.46 | 98.84 | RPA1 | rs5030740 | C/AGT | 0.30 | 99.42 | RPA1 | rs3744767 | T/C | 0.24 | 99.42 | RPA1 | rs3744769 | C/AGT | 0.22 | 97.69 | RPA1 | rs17734 | C/T | 0.43 | 99.42 |
|
|
MAF: minor allele frequency.
|